Management of physical pain during induced secondtrimester medical abortions: a cross-sectional study of methodological quality and recommendations in local clinical practice guidelines at Swedish hospitals.
Introduction
Induced abortion in the second trimester of pregnancy may be performed by means of drug-induced labour and vaginal delivery of the pregnancy (1), hereafter referred to as induced second-trimester medical abortion. Patients who undergo induced second-trimester medical abortions are at risk of intense physical pain (2) (3) (4) (5) (6) . Thus, appropriate pain management is an acknowledged indicator for quality abortion care (7) . However, pain management remains a clinical challenge (8, 9) , and studies indicate patient dissatisfaction with experienced insufficient pain treatment (5, 6) . Pain management concerns interventions that aim to assess, treat and reassess pain that patients experience. In order to achieve high-quality pain management, health professionals need to appropriately screen for the presence of pain, offer effective and safe treatment options, and frequently reassess pain to investigate how patients respond to the treatment (10) .
Local clinical practice guidelines are documents that summarise routines at hospitals, with the purpose to assist health professionals in their clinical decisions (11) . Such guidelines may bridge possible gaps between clinical decisions and scientific evidence, have the potential to improve consistency of care, may reduce patient morbidity (12) and are considered key components of modern pain management (13) . In addition to the importance of evidence-based recommendations for options of clinical management, guidelines need to be rigorously developed so that they meet criteria for high methodological quality (14, 15) . Although local clinical practice guidelines are widely developed in many countries, there is a lack of studies that investigate pain management recommendations in documents that describe abortion care. Consequently, the aim of this study was to assess the methodological quality and describe recommendations for management of physical pain in local clinical practice guidelines about induced second-trimester medical abortions at Swedish university and county hospitals.
Material and methods

Study context
Swedish law states that pregnant persons have the right to induced abortion until 18 completed weeks of gestation. At later gestations, approval must be sought and granted from the National Board of Health and Welfare (16) . In 2016, 2374 induced second-trimester abortions were performed in Sweden, corresponding to 6% of the total number of induced abortions. The large majority (>97%) of these were medical abortions (17) .
Data collection
In 2017, a list of all university and county hospitals in Sweden was collected from the Swedish Association of Local Authorities and Regions. The wards for gynaecology at these hospitals were contacted and asked to send any local clinical practice guidelines that described the care of patients undergoing induced second-trimester medical abortions. In total, seven university hospitals and 22 county hospitals reported that they provided such care. One county hospital declined participation, due to lack of current guideline, and all other consented to send their guidelines. One university hospital and two county hospitals did not send guidelines despite one reminder. Consequently, 25 guidelines from university (n = 6) and county (n = 19) hospitals were included.
Data analysis
Methodological quality assessment. The quality of the guidelines was assessed with two instruments. The AGREE II instrument (18) contains 23 items divided into six domains: scope and purpose (three items), stakeholder involvement (three items), rigour of development (eight items), clarity of presentation (three items), applicability (four items) and editorial independence (two items). The items were answered on a scale from 1 (strongly disagree) to 7 (strongly agree), with 1 indicating poor quality and 7 indicating exceptional quality. Each guideline assessment was concluded with a rating concerning the overall quality of the guideline, and a question of whether or not the assessor would recommend the guideline for use, with or without modifications. The final score for each domain was calculated in percentage of maximum possible score, resulting in a total score range of 0-100. No thresholds for scores that would indicate high quality have yet been established (18). Previous reports suggest that domain scores ≥50%-70% indicate high quality and scores <50% indicate low quality (18) (19) (20) (21) (22) . The instrument has shown adequate levels of reliability and validity (14, 18, 23) . In addition to the AGREE II instrument, a modified version of a previously used tool for assessment of guideline quality was used (24) . The tool included 10 criteria concerning development and format, 11 criteria concerning evidence identification and summary and nine criteria concerning formulation of recommendations. The author performed the quality assessments. The data were analysed with descriptive statistics using R version 2.3.3 (R Foundation for Statistical Computing, 2014). Fisher's exact tests and Mann-Whitney U-tests were used to investigate possible differences between university and county hospitals. p < 0.05 was considered statistically significant.
Recommendations for pain management. The assessment of recommendations described in the guidelines included two steps, involving three analysts to minimise the risk of bias and misinterpretation. In the first step, recommendations regarding pain management were individually assessed by two bachelor's level nursing students with regard to pain measurement, pharmacologic pain treatment and nonpharmacologic treatment. No differences between their assessments were observed. In the second step, the author scrutinised the initial assessments by reading all guidelines and compared the student's assessments with the described recommendations in the guidelines. Two minor errors were identified and corrected. The data were analysed using R version 2.3.3 (R Foundation for Statistical Computing, 2014). Fisher's exact tests were used to investigate possible differences between university and county hospitals. p < 0.05 was considered statistically significant.
Ethical approval
This study was an assessment of clinical practice guidelines, which are general documents that do not contain any personal information about individuals. No individuals were included as research subjects in the study. In Sweden, such studies are not required to undergo ethical review (25) .
Results
Methodological quality
Across all domains in the AGREE II instrument, the median scores of the included guidelines did not reach >25%, indicating low overall methodological quality ( Table 1) . The large majority of guidelines had <50% for all domains, including scope and purpose (n = 22, 88%), stakeholder involvement (n = 25, 100%), rigour of development (n = 25, 100%), clarity of presentation (n = 21, 84%), applicability (n = 25, 100%) and editorial independence (n = 25, 100%). The median score for the overall quality of the guidelines was 2 (range = 1-3). In total, 17 (68%) of the guidelines were recommended for use after modifications and eight (32%) were not recommended for use. With regard to the modified tool for assessment of guideline quality, the majority of guidelines (>50%) did not specify 7 of 10 criteria related to the development and format, 11 of 11 criteria related to evidence identification and summary and six of nine criteria related to formulation of recommendations (Table 2) . No significant differences were observed between university and county hospitals with regard to any of the investigated quality criteria in the AGREE II instrument and the modified tool for assessment of guideline quality.
Recommendations for pain management
In total, 24 (96%) guidelines described the management of physical pain. Few recommended pain measurements before (n = 4, 16%) and after (n = 3, 12%) administered treatment. Recommended measurement tools included Visual Analogue Scale (n = 3, 12%) and Numerical Rating Scale (n = 2, 8%). No guideline specified recommendations for frequency or interval of measurements.
Recommendations for prophylactic pharmacologic treatment were described in 23 (92%) guidelines, including paracetamol, anti-inflammatory drugs (n = 4 different drugs) and four opioids (n = 4 different opioids) ( Table 3) . With regard to recommendations for prophylactic pharmacologic treatment, no differences were observed between university and county hospitals. Recommendations for as needed pharmacologic treatment were described in 23 (92%) guidelines, including paracervical block, epidural analgesia, inhalation of nitrous oxide, opioids (n = 6 different opioids) and paracetamol (Table 4) . With regard to recommendations for as needed oxycodone, Fisher's exact test revealed a significant difference between university (n = 4, 67%) and county hospitals (n = 3, 16%).
Recommendations for adjuvant pharmacologic treatment included diazepam (n = 7, 28%) and oxazepam (n = 1, 4%). Nonpharmacologic methods were recommended in nine (36%) guidelines (Table 5) . With regard to recommendations for nonpharmacologic methods, no differences were observed between university and county hospitals. 
Discussion
Few guidelines contained recommendations for frequency or tools for pain measurement. Frequent and systematic measurement of physical pain, with the aid of validated tools, is a critical aspect in order to achieve care of high quality (10, (26) (27) (28) and essential for prompt treatment of pain (10) . Health professionals consider such Total  5  83  16  84  21  84  Morphine  Total  4  67  11  58  15  60  Intravenous injection  3  50  5  26  8  32  Subcutaneous injection  1  17  5  26  6  24  Oral  1  17  3  16  4  16  Not specified  0  0  3  16  3  12  Oxycodone  Total  4*  67  3*  16  7  28  Oral  3  50  2  11  5  20  Not specified  1  17  1  5  2  8  Ketobemidone  Total  2  33  5  26  7  28  Intravenous injection  0  0  3  16  3  12  Subcutaneous injection  1  17  2  11  3 tools to be valuable in their clinical work, as it helps them to gain an understanding of the pain experiences of their patients (29) . However, research shows that validated tools for pain measurements may be difficult to implement in clinical practice (30) and that health professionals often choose to assess intensity of physical pain with other, less validated, methods (31) . The lack of recommendations regarding which tools to use and which frequency to measure physical pain calls attention to the risk that health professionals may fail to recognise and treat physical pain among these patients. Future studies should investigate the possible clinical impact that unclear guidelines may have on pain measurements within abortion care. Current recommendations for pain management emphasise the importance of prophylactic and multimodal methods (10, 32) , which many of the guidelines included in the recommendations. Epidural analgesia and paracervical block, which are common and effective interventions for obstetric pain (33, 34) , were recommended in a proportion of the guidelines. However, its place in the pain management of patients undergoing medically induced abortion has been questioned (3, 35) , and few patients are administered these alternatives in clinical practice (36) . Moreover, 20% of the guidelines recommended inhalation of nitrous oxide, and nine guidelines recommended various types of nonpharmacologic methods. The varied recommendations with regard to nerve block techniques, inhalation of nitrous oxide and nonpharmacologic methods call attention to national inconsistencies in the documents. It is possible that these findings are expressions of the unclear evidence regarding optimal analgesia during medically induced abortions in the second trimester of pregnancy (2) and illustrate the possible need for national collaborations that aim to develop consensus guidelines concerning pain management.
A great risk associated with the use of clinical guidelines is that the recommendations may not be in line with current evidence. Thus, it is important that clinical guidelines are developed with systematic methods, within structured and coordinated programmes that promote the development of high-quality documents (37) . However, authors of these guidelines may lack the time or resources to identify and grade scientific reports with high enough quality, so that recommendations sufficiently reflect the evidence base (12) . The quality assessments in this study revealed that the majority of the documents did not contain details concerning most of the investigated criteria. The poor quality, confirmed with two separate instruments, calls attention to the importance of rigorous development of clinical practice guidelines and urge authors of these documents to make sure to include sufficient details about the development phase. The findings indicate that Swedish hospitals may need to invest more resources that support the production of these types of guidelines.
There are methodological limitations that need to be considered when interpreting the findings. First, 25 guidelines were included, which is a limited number when trying to achieve generalisability beyond Sweden. On the other hand, all Swedish university and county hospitals, according to a list collected from the Swedish Association of Local Authorities and Regions, were contacted and the majority sent their guidelines. This implies generalisability in settings similar to Sweden. Nevertheless, more research is needed in order to reach generalisable conclusions. Second, it is possible that recommendations for pain management failed to be recognised during the assessments. However, the assessors of recommendations for pain management had high similarity in their assessments of recommendations, which strengthens the internal validity. To further minimise the risk of misinterpretation and bias, the author scrutinised the assessments of recommendations and found only minimal errors. Third, the quality assessments were performed with the aid of two instruments, and it is possible that the used instruments did not include some important aspect of quality criteria. Moreover, only the author performed the quality assessments, implying a risk of bias. However, the AGREE II instrument has been shown to have adequate levels of validity and reliability (14, 23) , and previous studies indicate high interrater reliability when multiple assessors are used (19) (20) (21) (22) . This, combined with the fact that two separate instruments were used to assess methodological quality, strengthens the findings concerning poor quality. Lastly, it is possible that health professionals measure pain, even when not described in the documents, or offer more interventions than those recommended in the guidelines. Consequently, additional research is needed that investigates clinical pain management of patients who undergo induced second-trimester medical abortion.
Conclusion
The findings indicate that local clinical practice guidelines about induced second-trimester medical abortions are of inadequate quality and that a large majority lack recommendations concerning systematic pain measurements. Although most recommend prophylactic and as needed pharmacologic management, national inconsistencies exist in Sweden with regard to recommendations of epidural analgesia, nitrous oxide and nonpharmacologic methods. In Sweden, there is room for improvement in the development of these guidelines.
